These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10493133)

  • 1. Candida albicans pathogenicity: a proteomic perspective.
    Niimi M; Cannon RD; Monk BC
    Electrophoresis; 1999 Aug; 20(11):2299-308. PubMed ID: 10493133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic profiling of serologic response to Candida albicans during host-commensal and host-pathogen interactions.
    Pitarch A; Nombela C; Gil C
    Methods Mol Biol; 2009; 470():369-411. PubMed ID: 19089396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of proteomic analysis to the study of azole antifungal resistance in Candida albicans.
    Hooshdaran MZ; Hilliard GM; Rogers PD
    Methods Mol Med; 2005; 118():57-70. PubMed ID: 15888935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of virulence determinants of the human pathogenic fungi Aspergillus fumigatus and Candida albicans by proteomics.
    Kniemeyer O; Schmidt AD; Vödisch M; Wartenberg D; Brakhage AA
    Int J Med Microbiol; 2011 Jun; 301(5):368-77. PubMed ID: 21565549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Extracellular hydrolytic enzymes and their relevance during Candida albicans infections].
    Stehr F; Felk A; Kretschmar M; Schaller M; Schäfer W; Hube B
    Mycoses; 2000; 43 Suppl 2():17-21. PubMed ID: 11291571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular organization of the cell wall of Candida albicans and its relation to pathogenicity.
    Ruiz-Herrera J; Elorza MV; Valentín E; Sentandreu R
    FEMS Yeast Res; 2006 Jan; 6(1):14-29. PubMed ID: 16423067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression and hotspot mutations of the multidrug efflux transporter, CDR1 in azole-resistant Candida albicans isolates from vaginitis patients.
    Looi CY; D' Silva EC; Seow HF; Rosli R; Ng KP; Chong PP
    FEMS Microbiol Lett; 2005 Aug; 249(2):283-9. PubMed ID: 16006060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human fungal pathogen Candida albicans in the postgenomic era: an overview.
    Kabir MA; Hussain MA
    Expert Rev Anti Infect Ther; 2009 Feb; 7(1):121-34. PubMed ID: 19622061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative evaluation of tissue invasion by wild type, hyphal and SAP mutants of Candida albicans, and non-albicans Candida species in reconstituted human oral epithelium.
    Jayatilake JA; Samaranayake YH; Cheung LK; Samaranayake LP
    J Oral Pathol Med; 2006 Sep; 35(8):484-91. PubMed ID: 16918600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of proteins highly expressed in the hyphae of Candida albicans by two-dimensional electrophoresis.
    Choi W; Yoo YJ; Kim M; Shin D; Jeon HB; Choi W
    Yeast; 2003 Sep; 20(12):1053-60. PubMed ID: 12961753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrolytic enzymes as virulence factors of Candida albicans.
    Schaller M; Borelli C; Korting HC; Hube B
    Mycoses; 2005 Nov; 48(6):365-77. PubMed ID: 16262871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candida albicans strain-dependent virulence and Rim13p-mediated filamentation in experimental keratomycosis.
    Mitchell BM; Wu TG; Jackson BE; Wilhelmus KR
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):774-80. PubMed ID: 17251477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
    Krcmery V; Barnes AJ
    J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence mechanisms of Candida albicans.
    Cotter G; Kavanagh K
    Br J Biomed Sci; 2000; 57(3):241-9. PubMed ID: 11050778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparative isoelectric focusing and preparative electrophoresis of hydrophobic Candida albicans cell wall proteins with in-line transfer to polyvinylidene difluoride membranes for sequencing.
    Masuoka J; Glee PM; Hazen KC
    Electrophoresis; 1998 May; 19(5):675-8. PubMed ID: 9629897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candida dubliniensis, a new fungal pathogen.
    Gutiérrez J; Morales P; González MA; Quindós G
    J Basic Microbiol; 2002; 42(3):207-27. PubMed ID: 12111748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contributions of hyphae and hypha-co-regulated genes to Candida albicans virulence.
    Kumamoto CA; Vinces MD
    Cell Microbiol; 2005 Nov; 7(11):1546-54. PubMed ID: 16207242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis of Candida albicans yeast and hyphal cell wall and associated proteins.
    Ebanks RO; Chisholm K; McKinnon S; Whiteway M; Pinto DM
    Proteomics; 2006 Apr; 6(7):2147-56. PubMed ID: 16493703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candida albicans, the opportunist. A cellular and molecular perspective.
    Dupont PF
    J Am Podiatr Med Assoc; 1995 Feb; 85(2):104-15. PubMed ID: 7877106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo transcript profiling of Candida albicans identifies a gene essential for interepithelial dissemination.
    Zakikhany K; Naglik JR; Schmidt-Westhausen A; Holland G; Schaller M; Hube B
    Cell Microbiol; 2007 Dec; 9(12):2938-54. PubMed ID: 17645752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.